| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.04B | 2.41B | 1.74B | 2.07B | 2.46B | 2.38B |
| Gross Profit | 1.44B | 1.54B | 1.58B | 1.82B | 2.27B | 1.99B |
| EBITDA | 1.11B | -2.73B | -5.47B | 1.67B | 2.17B | 1.88B |
| Net Income | -3.71B | -3.75B | -5.79B | 801.41M | 1.35B | 727.98M |
Balance Sheet | ||||||
| Total Assets | 27.37B | 30.93B | 34.14B | 37.90B | 42.32B | 38.24B |
| Cash, Cash Equivalents and Short-Term Investments | 3.82B | 2.01B | 3.43B | 7.05B | 12.69B | 15.04B |
| Total Debt | 14.74B | 15.94B | 17.76B | 16.55B | 17.25B | 18.29B |
| Total Liabilities | 15.74B | 19.23B | 19.46B | 17.93B | 19.70B | 19.38B |
| Stockholders Equity | 11.62B | 11.69B | 14.45B | 19.44B | 21.72B | 18.23B |
Cash Flow | ||||||
| Free Cash Flow | 3.55B | 2.11B | -1.06B | -912.57M | 137.83M | 997.16M |
| Operating Cash Flow | 3.59B | 2.16B | -1.02B | -858.21M | 230.57M | 1.07B |
| Investing Cash Flow | 266.83M | -351.54M | -193.44M | 41.28M | -48.67M | -1.61B |
| Financing Cash Flow | -2.41B | -1.91B | 1.22B | -758.77M | -1.09B | 1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | HK$1.40B | 12.19 | 1.10% | ― | -7.70% | 101.92% | |
51 Neutral | HK$54.00M | -14.90 | -2.51% | ― | -45.97% | -380.00% | |
48 Neutral | HK$319.68M | 56.00 | 44.48% | ― | ― | ― | |
46 Neutral | HK$143.00M | -0.60 | -12.41% | ― | -25.00% | -209.09% | |
45 Neutral | HK$90.69M | -2.40 | -3218.89% | ― | ― | 60.85% | |
42 Neutral | HK$268.50M | -0.06 | -31.83% | ― | 154.99% | 32.20% |